Napo Pharmaceuticals, Inc. 201 Mission Street, Suite 2375 San Francisco, CA 94105Debt and Warrant Settlement Agreement • September 14th, 2017 • Jaguar Health, Inc. • Pharmaceutical preparations
Reference is hereby made to that certain Debt and Warrant Settlement Agreement, dated March 31, 2017 (the “Settlement Agreement”), by and among Dorsar Investment Company (together with all affiliates, collectively referred to herein as “Dorsar”), Alco Investment Company (“Alco”), Two Daughters LLC (“Two Daughters” and, together with Dorsar and Alco, collectively, the “Feinberg Parties” and each, individually, a “Feinberg Party”), and Napo Pharmaceuticals, Inc. (“Napo”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Settlement Agreement.
DEBT AND WARRANT SETTLEMENT AGREEMENTDebt and Warrant Settlement Agreement • April 18th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations
THIS DEBT AND WARRANT SETTLEMENT AGREEMENT (“Agreement”) dated this 31st day of March, 2017 (the “Agreement Date”), is made and entered into by and among (i) Dorsar Investment Company (together with all affiliates, collectively referred to herein as “Dorsar”), (ii) Alco Investment Company (“Alco”), (iii) Two Daughters LLC (“Two Daughters” and, together with Dorsar and Alco, collectively, the “Feinberg Parties” and each, individually, a “Feinberg Party”), (iv) Agent (as defined below) and (v) Napo Pharmaceuticals, Inc., a Delaware corporation (“Company”).
